Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
6
Bullish
4
Bearish
33
Neutral
6
Bullish
7
Bearish
29
Neutral
0
Bullish
3
Laxmi Dental Limited is an end‑to‑end integrated dental products and services company that manufactures crowns, bridges, dentures, clear aligners, thermoforming sheets, 3D printing resins, intraoral scanners and paediatric dental products across six manufacturing facilities while selling into 95+ countries and a 22,000+ strong dental network.
Q3FY26 revenue was INR 660.4 million, up 7.1% YoY, while adjusted metrics show pressures: gross margins at 69.5%, EBITDA fell to INR 69.7 million with adjusted EBITDA INR 96.1 million, and the quarter included an exceptional INR 57.8 million labour‑code provision that materially reduced reported PAT and margins.
The company’s strategic differentiation is its vertical integration — in‑house raw materials (Taglus), device manufacturing (iScanPro scanners), branded aligners (Illusion), and paediatric products (Kids‑e‑Dental) — plus regulatory credentials (US FDA 510(k), EU MDR conformity, ISO 13485) that support export leadership and premium product positioning.
Key near‑term catalysts and headwinds are clear: US tariffs have recently been reduced (from ~50% to 25%), EU FTA developments could open markets, and continued scanner penetration and aligner pricing normalisation could drive recovery; counter‑vailing risks include pricing competition in Bizdent and timing of regulatory approvals for Kids‑e‑Dental.
Balance sheet and cash flow are strong by FY25: consolidated cash and bank balances rose materially to ~INR 1,093.6 million, reflecting financing and operating cash generation that provides optionality for scaling manufacturing, working capital or strategic investments if management executes on expansion plans.
Healthcare Equipment & Supplies
Medical Equipment & Supplies
1,066 Cr
High Risk
30.7
56.6
0.6
4.4
344.60
155.65
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Laxmi Dental Ltd (LAXMIDENTL) is currently trading at 193.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Laxmi Dental Limited is an end‑to‑end integrated dental products and services company that manufactures crowns, bridges, dentures, clear aligners, thermoforming sheets, 3D printing resins, intraoral scanners and paediatric dental products across six manufacturing facilities while selling into 95+ countries and a 22,000+ strong dental network. Q3FY26 revenue was INR 660.4 million, up 7.1% YoY, while adjusted metrics show pressures: gross margins at 69.5%, EBITDA fell to INR 69.7 million with adjusted EBITDA INR 96.1 million, and the quarter included an exceptional INR 57.8 million labour‑code provision that materially reduced reported PAT and margins. The company’s strategic differentiation is its vertical integration — in‑house raw materials (Taglus), device manufacturing (iScanPro scanners), branded aligners (Illusion), and paediatric products (Kids‑e‑Dental) — plus regulatory credentials (US FDA 510(k), EU MDR conformity, ISO 13485) that support export leadership and premium product positioning. Key near‑term catalysts and headwinds are clear: US tariffs have recently been reduced (from ~50% to 25%), EU FTA developments could open markets, and continued scanner penetration and aligner pricing normalisation could drive recovery; counter‑vailing risks include pricing competition in Bizdent and timing of regulatory approvals for Kids‑e‑Dental. Balance sheet and cash flow are strong by FY25: consolidated cash and bank balances rose materially to ~INR 1,093.6 million, reflecting financing and operating cash generation that provides optionality for scaling manufacturing, working capital or strategic investments if management executes on expansion plans.
Over the past 52 weeks, Laxmi Dental Ltd has traded between a low of ₹155.65 and a high of ₹344.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Laxmi Dental Ltd has a market capitalization of approximately 1,065.92. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Laxmi Dental Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 30.65 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,065.92 Cr, Laxmi Dental Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Laxmi Dental Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Laxmi Dental Ltd is 30.65. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The earnings conference call for Q1 FY27 was held on August 12, 2026.
The Laxmi Dental IPO is a book-built issue of ₹698.06 crore, as reported.
The Board of Directors meeting is scheduled for Thursday, May 21, 2026.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
661.10 | 1,542 Cr | 27.23 | 3.16 | 0.00 | 22.63 | 19.42 | 9.98 | ||
193.70 | 1,066 Cr | 30.65 | 4.38 | 0.00 | 13.74 | 14.03 | 9.76 | ||
610.50 | 888 Cr | 52.54 | 5.66 | 0.00 | 13.22 | 14.71 | 6.63 | ||
459.00 | 796 Cr | 68.61 | 4.63 | 0.00 | 5.88 | 7.65 | 5.02 | ||
368.55 | 656 Cr | 22.45 | 3.22 | 0.00 | 14.31 | 18.03 | 8.19 | ||
142.95 | 635 Cr | 13.07 | 1.51 | 0.42 | 9.14 | 10.71 | 7.45 | ||
377.05 | 453 Cr | 20.83 | 3.63 | 0.27 | 16.42 | 22.13 | 15.38 | ||
| Median: 7 Co. | — | 377.05 | 796 Cr | 27.23 | 3.63 | 0.00 | 13.74 | 14.71 | 8.19 |
Investor Presentation
Q1 FY27
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Investor Presentation
Q3 FY25
